Clinical Trial Update: Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease [Phase 1]

View source ↗

Summary

Phase 1 pediatric trial using mesenchymal stem cells to treat perianal fistulas in Crohn's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Perianal Fistula

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Anthony Lembo | Conditions: Perianal Fistula Due to Crohn's Disease (Disorder) | Phase 1 | Status: TERMINATED